Ian Villamagna | Sales Specialist- DNA & RNA Therapeutics
Sartorius

Ian brings a distinctive blend of expertise in chemistry and physiology, leading to a thesis project focused on drug delivery and the development of polymeric nanoparticles to large animal models during his doctoral studies. Transitioning to industry, Ian spent nearly four years as a Field Application Scientist in the field of lipid nanoparticles for RNA and DNA vaccines and therapeutics. During this tenure, he played a pivotal role in guiding numerous clients through the process of developing lipid nanoparticle-based drugs, leading them from early preclinical stages to clinical manufacture. Presently, Ian is commercially responsible for Sartorius’ DNA and RNA Therapeutics portfolio within the Advanced Therapy Solutions division. In this role, he focuses on new business development and strategically partnering with customers to move novel nucleic acid therapies from preclinical to clinical stages.